Jen J, Powell S M, Papadopoulos N, Smith K J, Hamilton S R, Vogelstein B, Kinzler K W
Johns Hopkins Oncology Center, Baltimore, Maryland 21231.
Cancer Res. 1994 Nov 1;54(21):5523-6.
One hallmark of malignant potential is dysplasia, the disruption of normal morphology. While it is generally recognized that cancer is the result of a series of genetic changes, the relationship of these alterations and their timing to the advent of dysplasia remains obscure. To address this issue, 54 small benign colorectal lesions of various malignant potential were analyzed for APC and K-RAS mutations, two alterations which have been implicated in the early stages of colorectal tumorigenesis. APC mutations were closely associated with dysplasia. In contrast, K-RAS mutations were found to be remarkably common in small nondysplastic lesions which apparently have a limited potential to progress to larger tumors. These results provide evidence that the nature and order of genetic changes can have a specific impact on both tumor morphology (e.g., dysplasia) and the likelihood of tumor progression.
恶性潜能的一个标志是发育异常,即正常形态的破坏。虽然人们普遍认识到癌症是一系列基因变化的结果,但这些改变及其发生时间与发育异常出现之间的关系仍不清楚。为了解决这个问题,对54个具有不同恶性潜能的小的良性结直肠病变进行了APC和K-RAS突变分析,这两种改变与结直肠癌发生的早期阶段有关。APC突变与发育异常密切相关。相比之下,K-RAS突变在明显进展为更大肿瘤潜力有限的小的无发育异常病变中非常常见。这些结果提供了证据,表明基因变化的性质和顺序可对肿瘤形态(如发育异常)和肿瘤进展的可能性产生特定影响。